Evidence map›Paper›PMID 37318025›Full record

ArticleJournal of the American Heart Association2023

Statin Use and Stroke Rate in Older Adults With Atrial Fibrillation: A Population-Based Cohort Study.

Bisan Shweikialrefaee, Dennis T Ko, Jiming Fang, Andrea Pang, Peter C Austin, Paul Dorian, Sheldon M Singh, Cynthia A Jackevicius, Karen Tu, Douglas S Lee and 1 more

Abstract read
In one paragraph

Article in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bisan ShweikialrefaeeDepartment of Medicine University of Toronto Toronto Ontario Canada.
Dennis T KoDepartment of Medicine University of Toronto Toronto Ontario Canada.ORCID 0000-0001-6840-8051
Jiming FangICES (Formerly Known as the Institute for Clinical Evaluative Sciences) Toronto Ontario Canada.ORCID 0000-0002-4526-0987
Andrea PangICES (Formerly Known as the Institute for Clinical Evaluative Sciences) Toronto Ontario Canada.ORCID 0000-0003-3324-7168
Peter C AustinICES (Formerly Known as the Institute for Clinical Evaluative Sciences) Toronto Ontario Canada.ORCID 0000-0003-3337-233X
Paul DorianDepartment of Medicine University of Toronto Toronto Ontario Canada.ORCID 0000-0002-8244-3520
Sheldon M SinghDepartment of Medicine University of Toronto Toronto Ontario Canada.ORCID 0000-0002-8210-3112
Cynthia A JackeviciusICES (Formerly Known as the Institute for Clinical Evaluative Sciences) Toronto Ontario Canada.ORCID 0000-0001-5274-7251
Karen TuUniversity Health Network Toronto Ontario Canada.ORCID 0000-0003-0883-4934
Douglas S LeeDepartment of Medicine University of Toronto Toronto Ontario Canada.ORCID 0000-0001-7078-745X
Husam Abdel-QadirDepartment of Medicine University of Toronto Toronto Ontario Canada.ORCID 0000-0002-7105-7931

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Atherosclerotic disease is an important contributor to adverse outcomes in patients with atrial fibrillation (AF). There is limited recognition of the association between statin use and stroke rates in AF. We aimed to quantify the association between statin use and stroke rate in AF. Methods and Results Using linked administrative databases in Ontario, Canada, we conducted a population-based retrospective cohort study of patients, aged ≥66 years, diagnosed with AF between 2009 and 2019. We used cause-specific hazard regression to determine the association of statin use with stroke rate. We developed a second model to further adjust for lipid levels in the subset of patients with available measurements in the year before AF diagnosis. Both models adjusted for age, sex, heart failure, hypertension, diabetes, stroke/transient ischemic attack, vascular disease, and P2Y12 inhibitors at baseline, plus anticoagulation as a time-varying covariate. We studied 261 659 qualifying patients (median age, 78 years; 49% women). Statins were used in 142 834 (54.6%) patients, and 145 673 (55.7%) had lipid measurement(s) in the preceding year. Statin use was associated with lower stroke rates, with adjusted hazard ratios of 0.83 (95% CI, 0.77-0.88;

Indexed as

Atrial FibrillationHydroxymethylglutaryl-CoA Reductase InhibitorsStrokeAgedCohort StudiesFemaleHumansLipidsLipoproteins, LDLMaleOntarioRetrospective StudiesRisk FactorsHydroxymethylglutaryl-CoA Reductase InhibitorsLipidsLipoproteins, LDLatrial fibrillationlow‐density lipoprotein cholesterolstatinstroke

Identifiers

PMID37318025
PMCPMC10356038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.